|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | ||
| Income from discontinued operations | ||
| Income from continuing operations | ||
| Depreciation and amortization | ||
| Share-based compensation | ||
| Non-cash impact of impairments | ||
| Changes in deferred income taxes | ||
| Changes in inventories | ||
| Changes in receivables and other assets | ||
| Changes in accounts payable and other liabilities | ||
| Changes in income taxes payable | ||
| Other operating activities | ||
| Net cash provided by operating activities of continuing operations | ||
| Net cash used in operating activities of discontinued operations | ||
| Net cash provided by operating activities | ||
| Cash flows from investing activities: | ||
| Purchase of businesses acquired, net of cash acquired | ||
| Capital expenditures | ||
| Other investing activities | ||
| Net cash used in investing activities of continuing operations | ||
| Net cash provided by investing activities of discontinued operations | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Purchase of own shares by Employee Benefit Trust | ||
| Purchase of treasury shares | ||
| Proceeds from sale of treasury shares | ||
| Repayments of debt | ||
| Proceeds from debt | ||
| Change in bank overdrafts | ||
| Cash dividends | ||
| Other financing activities | ||
| Net cash used in financing activities | ||
| Change in cash, cash equivalents and restricted cash | ||
| Effects of exchange rate changes | ||
| Cash, cash equivalents and restricted cash, beginning of period | ||
| Cash, cash equivalents and restricted cash, end of period | ||
| Supplemental Disclosures: | ||
| Cash paid for income taxes | ||
| Cash paid for interest | ||
| Accrued capital expenditures | ||
| Accrued dividends |
Loading...
